Published June 5, 2024
| Version v1
Journal article
Open
On the Structure, Stability, and Cell Uptake of Nanostructured Lipid Carriers for Drug Delivery
Creators
- 1. University of Graz
- 2. University of Portsmouth
- 3. University of Chicago
- 4. Research Center Pharmaceutical Engineering
- 5. Medical University of Graz
Description
The efficacy of nanostructured lipid carriers (NLC) for drug delivery strongly depends on their stability and cell uptake. Both properties are governed by their compositions and internal structure. To test the effect of the lipid composition of NLC on cell uptake and stability, three kinds of liquid lipids with different degrees of unsaturation are employed. After ensuring homogeneous size distributions, the thermodynamic characteristics, stability, and mixing properties of NLC are characterized. Then the rates and predominant pathways of cell uptake are determined. Although the same surfactant is used in all cases, different uptake rates are observed. This finding contradicts the view that the surface properties of NLC are dominated by the surfactant. Instead, the uptake rates are explained by the structure of the nanocarrier. Depending on the mixing properties, some liquid lipids remain inside the nanocarrier, while other liquid lipids are present on the surface. Nanocarriers with liquid lipids on the surface are taken up more readily by the cells. This shows that the engineering of efficient lipid nanocarriers requires a delicate balance of interactions between all components of the nanocarrier on the molecular level.
Data availability
The data that support the findings of this study are available within the main text and Supporting Information. Any other relevant data are available from the corresponding author upon request.Files
jeitler-et-al-2024-on-the-structure-stability-and-cell-uptake-of-nanostructured-lipid-carriers-for-drug-delivery.pdf
Files
(10.8 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:a7cd75bbbcacf997a6319aac4c45daf1 |
9.9 MB | Preview Download |
|
Supporting information md5:31c2c7e647b1585c169dabc290d69834 |
894.9 kB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1021/acs.molpharmaceut.4c00392
- Other
- oai:uchicago.tind.io:13319
Funding
- University of Graz